Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 39, n° 5
pages 746-750 (novembre 1998)
Doi : 10.1016/S0190-9622(98)70047-7
Treatment of spider veins with the 595 nm pulsed-dye laser

Eric F. Bernstein, MDa, Jason Lee, MDa, Joe Lowery, MSb, Douglas B. Brown, MSa, Roy Geronemus, MDc, Gary Lask, MDd, James Hsia, PhDb
Philadelphia, Pennsylvania; Wayland, Massachusetts; New York, New York; and Los Angeles, California 


Background: Previous attempts to treat spider veins with the conventional 585 nm pulsed-dye laser with a 0.5-ms pulse duration have been relatively ineffective. Recently, a new pulsed-dye laser that is tunable from 585 to 600 nm with a pulse duration 3 times longer than previously available lasers has preliminarily been shown to be effective for treatment of spider veins. Objective: Our purpose was to evaluate the effectiveness of multiple treatments with the tunable long-pulse dye laser in treatment of spider veins of the lower extremity. Methods: Ten female volunteers were treated in two separate areas containing blue or red linear spider veins less than 1.5 mm in diameter. Treatments were administered with the pulsed-dye laser with a 1.5-ms pulse duration and 595-nm light at fluences of 15 and 20 J/cm2, and each subject received a total of 3 treatments at each site, administered at 6-week intervals. Photographs were taken before and 6 weeks after the last treatment. Results: Computer-based image analysis showed clearing of more than three fourths of veins after 3 treatments with 15 or 20 J/cm2. Side effects were minimal and the treatments were well tolerated. Conclusion: The 595 nm, 1.5 ms pulse duration, pulsed-dye laser is safe and effective for treating blue or red spider veins of the lower extremities less than 1.5 mm in diameter in nontanned patients with Fitzpatrick skin types I and II. Multiple treatments improve on the results obtained after a single treatment. (J Am Acad Dermatol 1998;39:746-50.)

The full text of this article is available in PDF format.

 From the Department of Dermatology and Cutaneous Biology, Jefferson Medical College, Thomas Jefferson University, Philadelphiaa; Candela Corporation, Waylandb; The Laser and Skin Surgery Center of New York, New Yorkc; and the Dermatology Laser Center, University of California Los Angeles Medical Center.d
 Reprint requests: Eric F. Bernstein, MD, Department of Dermatology, Thomas Jefferson University, 233 S 10th St, Suite 450, Philadelphia, PA 19107-5541. E-mail:
 0190-9622/98/$5.00 + 0   16/1/92724

© 1998  American Academy of Dermatology, Inc. Published by Elsevier Masson SAS@@#104157@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline